Oxford Square Capital Corp.
OXSQ Nasdaq Financials FY2020βFY2025
What Oxford Square Capital Corp. does
No business description yet.
- Legal name
- Oxford Square Capital Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 6, 2026
- Accession Β· CIK
- 0001213900-26-024280
0001259429
Revenue and margins
Oxford Square Capital Corp. had $21.1M of revenue in fiscal 2025, down 15.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Oxford Square Capital Corp. returned $31.3M to shareholders in fiscal 2025. The diluted share count rose 20.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Oxford Square Capital Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $9.0M | $9.0M | $5.7M | $34.9M | $51.9M |
| Debt incl. finance leases | β | β | $129M | β | β |
| Debt / equity | β | β | 0.9x | β | β |
| Total assets | $434M | $328M | $278M | $300M | $307M |
| Total liabilities | $189M | $189M | $126M | $139M | $161M |
| Shareholders' equity | $245M | $139M | $151M | $161M | $145M |
| Net debt (β = net cash) | β | β | $123M | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 1 | β / 3 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | 33.9% | β27.8% | β15.9% | β6.9% | β1.6% |
| Altman Z'' | β | β | β | β | β | β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | β | $17.4M | $25.2M | $33.6M | $24.9M | $21.1M |
| Net interest income | β | $17.4M | $25.2M | $33.6M | $24.9M | $21.1M |
| Interest expense | $7.9M | $10.5M | $12.4M | $10.8M | $7.8M | $9.2M |
| Net income | β | $39.6M | β$85.6M | $17.2M | $5.9M | β$18.7M |
| Diluted EPS | β | $0.32 | $0.42 | $0.51 | $0.42 | $0.30 |
| Diluted shares | β | 0.05B | 0.05B | 0.05B | 0.06B | 0.08B |
| Cash flow | ||||||
| Cash from operations | $95.1M | β$107M | $20.4M | $65.5M | $25.7M | β$13.7M |
| Dividends paid | $30.1M | $20.4M | $20.4M | $28.6M | $25.8M | $31.3M |
| Dividends and buybacks | $30.1M | $20.4M | $20.4M | $28.6M | $25.8M | $31.3M |
| Balance sheet | ||||||
| Cash and short-term investments | $59.1M | $9.0M | $9.0M | $5.7M | $34.9M | $51.9M |
| Total debt | β | β | β | $129M | β | β |
| Total assets | β | $434M | $328M | $278M | $300M | $307M |
| Total liabilities | β | $189M | $189M | $126M | $139M | $161M |
| Shareholders' equity | $225M | $245M | $139M | $151M | $161M | $145M |
| Margins | ||||||
| Net margin | β | 227.0% | β339.0% | 51.3% | 23.6% | β88.8% |
| Net interest share of revenue | β | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Returns | ||||||
| Return on equity | β | 16.8% | β44.6% | 11.9% | 3.8% | β12.2% |
| Return on assets | β | 9.1% | β22.5% | 5.7% | 2.0% | β6.2% |
| Return on tangible equity | β | 16.2% | β61.7% | 11.4% | 3.7% | β12.9% |
| Growth | ||||||
| Revenue growth | β | β | 44.7% | 33.1% | β25.8% | β15.4% |
| Net income growth | β | β | β316.1% | β | β65.9% | β418.6% |
| EPS growth | β | β | 31.3% | 21.4% | β17.6% | β28.6% |
| Share count change | β | β | 0.3% | 8.4% | 17.7% | 20.4% |
| Financial health | ||||||
| Debt / equity | β | β | β | 0.9x | β | β |
| Quality scores | ||||||
| Accruals ratio | β | 33.9% | β27.8% | β15.9% | β6.9% | β1.6% |
Source: SEC EDGAR XBRL filings (CIK 0001259429). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.